A new study led by researchers from the Wellcome Trust Centre for Human Genetics has identified genetic markers linked to resistance to the anti-malarial drug piperaquine. This new information can be used as a tool to identify areas where resistance is emerging and where current treatment strategies are likely to fail.
Scientists identify genetic marker for resistance to malaria treatment in Cambodia
8 November 2016
Global efforts to try and treat and eradicate malaria are being hampered by increasing resistance of the disease-causing Plasmodium parasite to anti-malarial drugs.